Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 3
2016 3
2017 2
2018 4
2019 2
2020 3
2021 3
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Outreach, Screening, and Randomization of APOE ε4 Carriers into an Alzheimer's Prevention Trial: A global Perspective from the API Generation Program.
Walsh T, Duff L, Riviere ME, Tariot PN, Doak K, Smith M, Borowsky B, Lopez Lopez C, Arratia PC, Liu F, Scholten I, Gordon D, Arbuckle J, Graf A, Quinn M, Ricart J, Langbaum JB. Walsh T, et al. J Prev Alzheimers Dis. 2023;10(3):453-463. doi: 10.14283/jpad.2023.27. J Prev Alzheimers Dis. 2023. PMID: 37357285 Free PMC article. Clinical Trial.
Rationale for the selection of dual primary endpoints in prevention studies of cognitively unimpaired individuals at genetic risk for developing symptoms of Alzheimer's disease.
Caputo A, Racine A, Paule I, Tariot PN, Langbaum JB, Coello N, Riviere ME, Ryan JM, Lopez CL, Graf A; National Alzheimer’s Coordinating Center; Alzheimer’s Disease Neuroimaging Initiative. Caputo A, et al. Alzheimers Res Ther. 2023 Mar 6;15(1):45. doi: 10.1186/s13195-023-01183-z. Alzheimers Res Ther. 2023. PMID: 36879340 Free PMC article.
Pimavanserin and dementia-related psychosis.
Tariot PN, Ballard C, Devanand DP, Cummings JL, Sultzer DL. Tariot PN, et al. Lancet Neurol. 2022 Feb;21(2):114-115. doi: 10.1016/S1474-4422(21)00466-X. Lancet Neurol. 2022. PMID: 35065031 No abstract available.
26 results